Farm Animal Healthcare: By Product (Drugs, Vaccines, Feed and Diagnostic), By Animal Type (Companion Animal, and Livestock Animal), By End-use (Veterinary hospitals & clinics, Animal care & rehabilitation centers, Diagnostics Centers and Others) And Region - Global Analysis of Market Size, Share & Trends for 2019-2020 And Forecasts To 2031
Global Farm Animal Healthcare was valued at 35.6 billion in 2021 at a CAGR of 7.8%
Animal health refers to the treatment of medical disorders in animals through the use of specialized animal feeds, medications, vaccinations, and diagnostic devices. Animals are extremely important in human life. Animals, like humans, are susceptible to sickness and hence require comprehensive care from veterinarians & pet owners. The primary goal of the animal’s health sector is to improve and treat the health as well as well-being of companions and farm animals. Other than feeding livestock and pet food, the animal health sector covers any items and services that increase livestock production and animal health.
Global Farm Animal Healthcare market is expected to project a notable CAGR of 7.8% in 2031.
Global Farm Animal Healthcare was valued at 35.6 billion in 2021 at a CAGR of 7.8%. The rise of the Animal Health Insurance market will be fueled by growing pet owner knowledge of animal health issues. The industry will continue to rise as a result of multiple government initiatives to assist pet healthcare.
Drug segment to grow with the highest CAGR during 2021-31
Drugs, vaccinations, feed, and diagnostics are among the market segments based on products. The drug segment has the biggest market share among the services. Throughout the forecast period, the category is expected to maintain its dominance. This is due to an increase in the prevalence of numerous diseases in animals, as well as an increase in the number of prescriptions to cure them. Animal disease prevention, control, and eradication necessitate the use of these medications.
Companion animals’ segment to grow with the highest CAGR during 2021-31
Livestock animals & companion animals are two market sectors for animals. Due to the growing tendency of keeping pets at home, the companion animals sector maintained the biggest veterinary healthcare market share. Furthermore, by the end of the forecast period, this category is expected to rise fast, owing to the rising rate of pet ownership to help the elderly & physically challenged, as well as a shift in attitude of pet owner to pet nurture.
Incidences of zoonotic diseases are on the rise
Another important reason driving the growth of the US animal healthcare industry is the increasing incidence of food-borne zoonotic diseases. Some transmissible diseases in vertebrate animals, such as tuberculosis and avian flu, can be transmitted directly and indirectly to humans. Consumers can contract anisakiasis, a human’s zoonotic illness caused by specific species of nematodes, if they eat undercooked fish that contains worms. With the rise of food-borne zoonotic diseases, animal farm owners & pet owners are becoming increasingly concerned about animal health. In some regions, brucellosis (a bacterial infection that causes stillbirth) is on the rise. As a result, consumption of animal health products is growing substantially for the treatment of food-borne zoonotic diseases.
Increasing research and development in veterinary medicine
The increase of veterinary products & medicines is being aided by the International Animal Healthcare Market. The market's growth will be aided by a rise in the acceptance of companion animals, as well as an increase in meat and milk consumption. Modern technical improvements in the healthcare sector will also have a favorable impact on market expansion. Human health may be harmed by diseases that affect animals. Keeping track of diseases in animals is easier, more efficient, and far less expensive than keeping track of diseases in humans. Clean water, nutrition, a healthy environment, and, most importantly, disease immunizations are all effective strategies to keep animals healthy and avoid illness.
Government Regulations over animal drugs
Restrictions placed by government regulators on the usage of antibiotics are a key impediment to the expansion of the animal healthcare business. Animals are given antibiotics for both therapeutic and non-therapeutic causes. It has been discovered that giving animals an excessive number of antibiotics has a negative impact on consumer health.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Global Farm Animal Healthcare market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. During the projected period, North America will have the highest share of the global animal healthcare market. North America is scientifically technologically advanced of pharmaceuticals and diagnostics research and development, indicating that it is the dominant geography. Furthermore, the region has seen a considerable increase in pet adoption as well as an increase in zoonotic illness cases.
The COVID-19 pandemic is expected to have a significant impact on the market. There is a wealth of information on coronavirus in animals, including its evolution and pathogenesis. The spread of coronavirus through one species to others can be studied using swine coronavirus illness as a model. Porcine delta coronavirus was recognized as the causative factor of severe diarrhea outbreaks in Asia and north America, according to a study published in Current Opinion in Virology titled " Porcine delta coronavirus enters cells by two routes: a protease-mediated one on cell membrane, and a cathartic release-mediated one in the endosome."
Report Attribute |
Details |
Market size value in 2021 |
35.6 billion |
Revenue forecast in 2031 |
75.1 billion |
Growth Rate |
CAGR of 7.8% from 2021 to 2031 |
Base year for estimation |
2020 |
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2031 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Animal Type, Product, End-use and Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Key companies profiled |
Boehringer Ingelheim GmbH, Virbac SA, Elanco, Bayer AG, Intas Pharmaceuticals, Zydus Animal Health, Merck Animal Health, Zoetis, Inc., Vetoquinol SA, Ceva Sante Animale and Other Prominent Players. |
Global Farm Animal Healthcare was valued at 35.6 billion in 2021 at a CAGR of 7.8%
Animal health refers to the treatment of medical disorders in animals through the use of specialized animal feeds, medications, vaccinations, and diagnostic devices. Animals are extremely important in human life.
Drugs and Companion animal’s segments accounted for the largest Farm Animal Healthcare market share.
Key players: Boehringer Ingelheim GmbH, Virbac SA, Elanco, Bayer AG, Intas Pharmaceuticals, Zydus Animal Health, Merck Animal Health, Zoetis, Inc., Vetoquinol SA, Ceva Sante Animale are the key players in the Farm Animal Healthcare market.
The market is being driven by the Incidences of zoonotic diseases are on the rise and Increasing research and development in veterinary medicine is also likely to drive the market demand in the forecasted period, i.e., 2021-2031.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT